Follow On:
Chinese
ICBP2025

CFP

Call for Papers

    All manuscripts selected by the 13th International Conference on Biomedicine and Pharmaceutics (ICBP 2025) can be expanded and submitted by the authors to particular journals indexed in Web of Science, EI Compendex, and Scopus for peer review and publication. The decision on publication will depend on the peer-review process. The article recommended by the conference greatly increases the chance of acceptance.

    Notes: Guides on submission and author instructions of your preferred journal will be provided separately via an email after the conference.

    The topics include (but not limited to as followings):

Topics

Drug Discovery and Development
  • Drug Design
  • Pharmaceutical Formulation
  • Pharmaceutical Process
  • Lead Generation
  • Target Identification and Validation
  • Simulation Approaches in Drug Development
  • Pharmaceutical Transformation Quality
  • In-Vitro and in-Vivo Performance Testing
  • Pharmacogenetics and Pharmacogenomics
Drug Delivery and Translation
  • Antibody Targeting
  • Protein/Peptide Delivery
  • Image-guided Drug Therapy
  • Modes of Drug Entry
  • Drug Delivery Systems and Biocompatibility
  • DNA, Oligonucleotide and siRNA Delivery
  • Microcapsules, Liposomes, Vesicles and Macromolecular Conjugates
  • Devices for Drug Delivery and Drug/Device Combination Products
Pharmacokinetics
  • Therapeutic Drug Monitoring
  • Drug Absorption and Disposition
  • Metabolism and Excretion of Drugs
  • Drug Transporters
  • Pharmacokinetics and Pharmacodynamics
  • Toxicokinetics and Toxicodynamics
  • Drug-drug Interactions and Enzyme Kinetics
  • Application of Machine Learning to Pharmacokinetics-pharmacodynamics
Drug Safety and Toxicity
  • Drug-drug Interactions
  • Adverse Drug Reactions
  • Mechanisms of Drug Toxicity
  • Pharmacovigilance
  • Drug Safety Evaluations
  • Safety in 'At-risk' Patient Populations
  • Risk Analyses of Drugs and Drug Classes

Instructions for Authors

1. Please submit the manuscript (Word/PDF) to conference (Not less than 4000 words, Manuscript Name: "Author's Name+Tel");
2. The manuscript is the author's original research results, with substantial and complete content, reliable data, clear graphs and certain innovation;
3. The manuscript does not have multiple submissions, and has not been publicly published in other proceedings or journals;
4. The checking rate of manuscripts should be less than 20%, and the language should be free of obvious grammatical errors;
5. Please refer to the "Manuscript template" in the "Download" to adjust the paper format.